Timothy J. Richmond is CHRO & VP at AbbVie Inc. (ABBV). They have made 16 open-market trades across 1 company since 2014, most recently 2025-03-03.
CIK 0001563523
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 6,730 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2025-03-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2025-03-03 | 2025-03-04 | $210.44 | $8.8M | +2.3% | -2.6% | -9.7% |
| ABBV | SELL · 10b5-1 | 2025-02-26 | 2025-02-28 | $202.92 | $11.9M | +1.0% | -0.2% | -11.6% |
| ABBV | SELL · 10b5-1 | 2024-03-01 | 2024-03-05 | $177.27 | $26.8M | -0.3% | -5.9% | -10.2% |
| ABBV | SELL | 2023-03-01 | 2023-03-02 | $153.28 | $13.5M | -0.3% | +3.9% | -10.6% |
| ABBV | SELL | 2022-12-12 | 2022-12-14 | $163.44 | $13.9M | -0.5% | -6.3% | -6.1% |
| ABBV | SELL | 2022-03-01 | 2022-03-01 | $148.26 | $7.8M | +0.9% | +9.8% | -0.2% |
| ABBV | SELL | 2021-12-06 | 2021-12-08 | $120.00 | $6.0M | +7.1% | +10.4% | +20.4% |
| ABBV | SELL | 2021-03-01 | 2021-03-02 | $108.59 | $4.2M | +1.3% | +1.6% | +5.0% |
| ABBV | SELL | 2020-11-27 | 2020-12-01 | $105.00 | $5.5M | +2.3% | +3.0% | +4.2% |
| ABBV | SELL | 2020-05-05 | 2020-05-07 | $85.00 | $1.7M | +8.0% | +12.0% | +10.5% |
| ABBV | SELL | 2019-09-27 | 2019-10-01 | $75.02 | $2.3M | +1.0% | +9.1% | +21.4% |
| ABBV | SELL · 10b5-1 | 2018-06-15 | 2018-06-19 | $99.47 | $1.7M | -5.7% | -8.4% | -2.9% |
| ABBV | SELL | 2018-02-28 | 2018-03-02 | $118.67 | $4.3M | +4.4% | -19.7% | -13.1% |
| ABBV | SELL | 2017-12-18 | 2017-12-19 | $98.45 | $8.6M | +0.6% | +6.1% | +14.5% |
| ABBV | SELL | 2017-03-10 | 2017-03-10 | $65.29 | $2.9M | -0.5% | -1.4% | +4.4% |
| ABBV | SELL | 2016-05-10 | 2016-05-12 | $63.52 | $2.7M | -2.2% | -3.5% | +7.0% |
| ABBV | SELL | 2016-02-29 | 2016-03-02 | $55.09 | $823K | +2.7% | +3.1% | +13.0% |
| ABBV | SELL · 10b5-1 | 2015-02-27 | 2015-03-03 | $60.33 | $868K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL · 10b5-1 | 2015-02-17 | 2015-02-19 | $58.70 | $14K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL | 2014-02-18 | 2014-02-19 | $51.23 | $24K | -11.8% | -0.8% | -0.8% |
| ABBV | SELL | 2014-02-05 | 2014-02-07 | $47.78 | $70K | -11.8% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.